WhatsApp
backNews Article

Mankind Pharma Announces Participation in 2026 Jefferies Global Healthcare Conference in London from November 16-19

Company officials to engage in one-on-one and group investor meetings without disclosing unpublished price sensitive information

Mankind Pharma announces its participation in the 2026 Jefferies Global Healthcare Conference scheduled from November 16 to 19, 2026, in London, involving one-on-one and group meetings with investors and analysts. The company confirms no unpublished price sensitive information will be shared during these engagements, focusing only on publicly available general business outlooks.

06 Nov 2026|MANKIND+0.54%
Mankind Pharma LimitedMANKINDInvestor Presentation

Mankind Pharma Limited

Investor Presentation

Mankind Pharma has confirmed that company officials will participate in the 2026 Jefferies Global Healthcare Conference in London from November 16 to 19, 2026, conducting one-on-one and group meetings with investors and analysts.

The company stated that no unpublished price sensitive information will be disclosed during these meetings, which will be based solely on the general business outlook and information already available in the public domain.

The schedule of participation is subject to change depending on exigencies from either party.

Details of this participation have been uploaded on Mankind Pharma’s official website for transparency and investor information.

Highlights

  • Participation in 2026 Jefferies Global Healthcare Conference from November 16-19, 2026
  • Location: London
  • Meeting type: One-on-One and Group Meetings with investors and analysts
  • No unpublished price sensitive information will be shared
  • Company confirms schedule may change due to exigencies
  • Participation details available on www.mankindpharma.com

Key Data Snapshot

Event Name2026 Jefferies Global Healthcare Conference
Event DatesNovember 16 to November 19, 2026
LocationLondon
Meeting TypesOne-on-One / Group Meeting
Unpublished Price Sensitive Information DisclosureNone

What happened

  • Mankind Pharma officials will participate in the 2026 Jefferies Global Healthcare Conference in London between November 16 and 19, 2026.
  • The company plans to hold one-on-one and group meetings with investors and analysts during the conference.

Key details

  • No unpublished price sensitive information will be disclosed during investor interactions, restricted to general business outlook and publicly available data.
  • The schedule of the conference and company participation is subject to change due to possible exigencies on either side.
  • Information regarding participation has been made publicly available through the company's website.

More News on Investor Presentation

View all

Latest corporate announcements and market updates in Investor Presentation.

View all news
Mankind Pharma Announces Participation in 2026 Jefferies | Stockk News